Our Healthcare News

Encore Dermatology, Inc. Announces the Launch of IMPOYZ (clobetasol propionate) Cream, 0.025%, a Newly Formulated High-Potency Topical Corticosteroid

MALVERN, Pennsylvania—Encore Dermatology Inc. announces today the availability of a new topical product, IMPOYZ Cream, indicated for the treatment of moderate to severe plaque psoriasis…  

May 01 2018

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners - Company will Rebrand as EyePoint Pharmaceuticals, Inc.

WATERTOWN, Massachusetts(GLOBE NEWSWIRE)—pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the acquisition of Icon Bioscience…  

Mar 28 2018

EUSA Pharma Appoints Industry Veteran Rolf K Hoffmann to its Board of Directors

HEMEL HEMPSTEAD, England –– EUSA Pharma (EUSA), a world-class specialty pharmaceutical company focused on oncology and oncology supportive care, today announced the appointment of Rolf…  

Mar 07 2018

Cota Announces $40 Million Series C Financing to Advance Classification System

NEW YORK, NY—Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series…  

Feb 21 2018

AxoGen, Inc. Announces Proposed Public Offering of Common Stock

ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that…  

Nov 15 2017

EUSA Pharma and AVEO Oncology Announce First Commercial Launch of FOTIVDA (tivozanib)

HEMEL HEMPSTEAD, England & CAMBRIDGE, Massachusetts. – – EUSA Pharma and AVEO Oncology (NASDAQ: AVEO) today announced the first commercial launch of FOTIVDA® (tivozanib) with…  

Nov 15 2017

Grupo Biotoscana Acquires Laboratorio DOSA

Montevideo, Uruguay - - GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced the acquisition of Laboratorio DOSA S.A., a specialty…  

Nov 13 2017

Biotoscana Announces Launch of ABRAXANE/ABRAXUS in Brazil and Mexico

MONTEVIDEO, Uruguay—BIOTOSCANA INVESTMENTS S.A. (“Company” or “GBT”) (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general…  

Nov 01 2017

EW Healthcare Partners Announces the Appointment of Three Senior Executives

NEW YORK, New York—EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of three senior…  

Oct 18 2017

View Legacy Fund news >